The National Institutes of Health is offering a grant opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)". This grant aims to support research on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The grant will focus on reducing prenatal alcohol exposure and the incidence of FASD through prevention approaches, as well as developing interventions for FASD. The grant will be awarded through the Exploratory/Developmental Phased Award (R61/R33) mechanism, with the R61 phase supporting pilot studies and hypothesis development, and the R33 phase allowing for expanded research testing. Priority will be given to applications with clinical trials. Other eligible applicants include various institutions, organizations, and agencies. The grant has a closing date of November 16, 2026, and an award ceiling of $350,000. For more information and to apply, visit the following link: Grant Information.